Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)

Name: Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)
License: Public Domain

The Netherlands Cancer Institute

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

stomach cancer, gastro esophageal junction cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 217045
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.